New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance

Elias Jabbour, Jorge Cortes, Susan O'Brien, Francis Giles, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences